Successful infliximab therapy in a patient with comorbid spondyloarthritis, primary biliary cirrhosis and generalized morphea
| Autor: | Sevilay Kiliç, Ferhat Gökmen, Selda Işik, Hatice Reşorlu |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Infliximab therapy
medicine.medical_specialty Gastroenterology Scleroderma Localized 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Primary biliary cirrhosis Internal medicine Spondylarthritis medicine Humans skin and connective tissue diseases 030203 arthritis & rheumatology medicine.diagnostic_test Liver Cirrhosis Biliary business.industry General Medicine Middle Aged medicine.disease Infliximab Antirheumatic Agents Erythrocyte sedimentation rate Female business Generalized scleroderma medicine.drug |
| Zdroj: | Acta Clinica Belgica. 72:365-368 |
| ISSN: | 2295-3337 1784-3286 |
| Popis: | The patient in this report was diagnosed simultaneously with primary biliary cirrhosis (PBC), spondyloarthritis, and generalized morphea and was started on infliximab therapy. In addition to an improvement in clinical symptoms with this therapy, an improvement was also observed in laboratory parameters such as cholestatic enzymes, C-reactive protein, and erythrocyte sedimentation rate. Infliximab was well tolerated in this 56-year-old patient. However, further studies must be performed in order to clarify the therapeutic role of TNF-α blockers in, PBC and generalized morphea. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|